Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 239 (abbreviated as RNA5SP239) is a human **pseudogene** related to the 5S ribosomal RNA gene. Unlike the canonical 5S rRNA genes which encode a structural RNA essential for ribosome function and protein synthesis[5][3], this pseudogene does not encode a functional RNA or protein. Pseudogenes like RNA5SP239 are generally considered non-functional remnants of previously functional genes, generated through gene duplication or retrotransposition events[1][2]. While most pseudogenes have no biological role, emerging evidence suggests some can influence gene expression by acting as molecular decoys for microRNAs, as sources of regulatory RNAs, or through interaction with epigenetic regulators[4][6]. However, there is no direct evidence that RNA5SP239 specifically participates in such mechanisms or is involved as a therapeutic target, biomarker, or in disease contexts. It is not considered a therapeutic target, receptor, enzyme, transporter, or transcription factor. **Note:** - This entry is *not a drug target, enzyme, or receptor*. It is a **pseudogene**, and the gene product is *not known to exert direct biological activity or serve as a therapeutic target*[1][2]. - The naming and classification are correct (as a pseudogene), but **not a target**, so `is_incorrect` should be marked as true for any list of canonical therapeutic targets. - If you are seeking actionable drug targets, this gene is not relevant.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 239 (RNA5SP239).